Engineered exosomes have become popular drug delivery carriers for cancer treatment.
This is partially due to the interesting property, ie exosome organotropism, which plays an …

Background Treatment multiple tumors by immune therapy can be achieved by mobilizing
both innate and adaptive immunity. The programmed death ligand 1 (PD-L1; or CD274, B7-H1…

Background and aims The complex process of cancer metastasis remains the least understood.
Tumor cells alter their protein expression profile to survive from the tumor metastasis. …

There are disease-causing biohazards in the blood that cannot be treated with modern
medicines. Here we show that an intelligently designed safe biomaterial can precisely identify, …

Combination therapy offers promising opportunities for treating advanced non-small cell
lung cancer (NSCLC). Here, we established a chitosan-based nanocomplex CE7Q/CQ/S to …

Metastasis is the leading cause of melanoma-related mortality. Current therapies are rarely
curative for metastatic melanoma, revealing the urgent need to identify more effective …

Background Sorafenib is approved as a standard therapy for advanced hepatocellular
carcinoma (HCC), but its clinical application is limited due to moderate therapeutic efficacy and …

Time-staggered administration of erlotinib (Er) and doxorubicin (DOX) provides significantly
enhanced apoptosis of lung cancer cells, but this administration approach has not been …

Each type of cancer has its own specific metastatic route developed by disseminating circulating
tumor cells (CTCs) and related extracellular vesicles to the target organ, ie, metastasis …

The construction of multifunctional theranostic nanoplatforms to integrate accurate imaging
and enhanced therapy to treat tumors is highly attractive but remains a challenge. Here, we …